Shattuck Labs Inc. (STTK)
STTK trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$5.49
-9.85% on the day
Market cap
$551.0M
Small cap
Revenue · 2025
$1.0M
-82.5% on 2024
Net income · 2025
-$48.8M
-4880.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | STTK on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001680367 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.0M |
| Net income | -$48.8M |
| Operating income | -$51.5M |
| Net margin | -4880.9% |
| Operating margin | -5150.8% |
| Revenue growth | -82.5% |
| Cash | $54.2M |
| Total assets | $91.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 551.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-11 |
| Latest annual report | 10-K | 2026-03-05 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-11 |
| Latest proxy | DEFA14A | 2026-04-08 |
Source: SEC EDGAR submissions feed, 410 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.9% |
| 1 month | -9.0% |
| 3 months | -23.1% |
| Year to date | +48.9% |
| 1 year | +195.4% |
| From 52-week high | -32.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SLN | Silence Therapeutics Plc American Depository Share | $8.87 | -8.08% | $551.3M |
| FTH | Faeth Therapeutics Inc. | $21.51 | -7.48% | $555.8M |
| SGMT | Sagimet Biosciences Inc. Series A | $7.98 | -9.32% | $562.9M |
| PHAT | Phathom Pharmaceuticals Inc. | $7.00 | -1.82% | $566.3M |
| CRMD | CorMedix Inc. | $7.39 | -0.94% | $576.0M |
| PBYI | Puma Biotechnology Inc | $10.12 | -1.65% | $522.4M |
| AQST | Aquestive Therapeutics Inc. | $4.67 | -2.91% | $586.1M |
| NVCT | Nuvectis Pharma Inc. | $18.15 | -7.82% | $591.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier